Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by RegisPhilbinon Apr 12, 2018 11:32am
174 Views
Post# 27873421

RE:What am I missing here?

RE:What am I missing here?In my opinion, the true strength of Aphria lays with the fundamental principals of the company and the experienced management.  This is a company worth long term investment and isn't going anywhere.  I could care less about the "Big 3" per say, we know this company has been built for long term success and the day to day swings are related to the industry being largely speculative at this point.

That being said, Aphria has set itself up for long term success by tapping into the global market.  Anyone that thinks the Nuuvera deal wasn't benefical is crazy and just buying into the fear sentiment that is propogated throughout msm.

Aprhia will continue to bring in supply agreements, which in my opionion is the key to maintaining growth within the industry.  ACB shouldn't even be in the same conversation as APH.  As the global market continues to open, Aphria will continue to eat up the demand for product.  There will be enough pie for WEED and APH to get their fill.

There are plenty of small market cap companies to play the swings, this is a company geared toward long term success and the day to day fluctuations should be taken with a grain of salt.
Bullboard Posts